盈健醫療(01419.HK)年度扭虧為盈至1.45億港元
格隆匯9月27日丨盈健醫療(01419.HK)公吿,集團於2021財年收益約為6.55億港元,同比增加約44.3%。集團公司擁有人應占溢利約為1.45億港元,2020財年公司擁有人應占虧損約4040萬港元,扭虧為盈;2021財年每股基本盈利約為38.1港仙;董事會建議就2021財年宣派每股12港仙的末期股息。
2021財年,在疫情籠罩下,全球企業及個人均面臨前所未有的挑戰。為應對香港波動的疫情,集團竭力維持核心醫療業務高水準服務質素,謹慎把握新機遇,同時採取積極措施、施行有效的風險管理及成控制,從而儘量減少疫情帶來的負面影響。集團的靈活性戰略令集團在疫情的危機中得以在醫療領域競爭中脱穎而出。作為香港領先的私營醫療服務營運商之一,集團在極為艱難的商業環境中錄得傲人佳績。
公司擁有人應占溢利增加主要由於(i)全科醫療服務收益增加,此乃由於全科醫療服務範疇如預防、檢測、疫苗接種及外展服務擴展,當中包括疫情相關服務;(ii)毛利增加,此乃由於收益增加以及服務範疇多樣化及不同服務組合配合不同成本結構導致全科醫療服務及專科醫療服務的毛利率上升;及(iii)應課税溢利增加導致所得税開支增加抵銷所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.